Genomic predictors of physical activity and athletic performance.


Journal

Advances in genetics
ISSN: 0065-2660
Titre abrégé: Adv Genet
Pays: United States
ID NLM: 0370421

Informations de publication

Date de publication:
2024
Historique:
medline: 23 6 2024
pubmed: 23 6 2024
entrez: 22 6 2024
Statut: ppublish

Résumé

Physical activity and athletic performance are complex phenotypes influenced by environmental and genetic factors. Recent advances in lifestyle and behavioral genomics led to the discovery of dozens of DNA polymorphisms (variants) associated with physical activity and allowed to use them as genetic instruments in Mendelian randomization studies for identifying the causal links between physical activity and health outcomes. On the other hand, exercise and sports genomics studies are focused on the search for genetic variants associated with athlete status, sports injuries and individual responses to training and supplement use. In this review, the findings of studies investigating genetic markers and their associations with physical activity and athlete status are reported. As of the end of September 2023, a total of 149 variants have been associated with various physical activity traits (of which 42 variants are genome-wide significant) and 253 variants have been linked to athlete status (115 endurance-related, 96 power-related, and 42 strength-related).

Identifiants

pubmed: 38908902
pii: S0065-2660(24)00001-4
doi: 10.1016/bs.adgen.2024.01.001
pii:
doi:

Substances chimiques

Genetic Markers 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

311-408

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Ildus I Ahmetov (II)

Research Institute for Sport and Exercise Sciences, Liverpool John Moores University, Liverpool, United Kingdom; Sports Genetics Laboratory, St Petersburg Research Institute of Physical Culture, St. Petersburg, Russia; Laboratory of Genetics of Aging and Longevity, Kazan State Medical University, Kazan, Russia; Department of Physical Education, Plekhanov Russian University of Economics, Moscow, Russia. Electronic address: genoterra@mail.ru.

George John (G)

Transform Specialist Medical Centre, Dubai, United Arab Emirates.

Ekaterina A Semenova (EA)

Department of Molecular Biology and Genetics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia; Research Institute of Physical Culture and Sport, Volga Region State University of Physical Culture, Sport and Tourism, Kazan, Russia.

Elliott C R Hall (ECR)

Faculty of Health Sciences and Sport, University of Stirling, Stirling, United Kingdom.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH